Patents by Inventor Robert Casson

Robert Casson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Photobiomodulation device for treating retinal disease
    Patent number: 12527970
    Abstract: An ophthalmic treatment device for photobiomodulation of a retina comprising: a treatment light source producing a continuous wave or quasi-continuous wave output beam having a wavelength in the range of 600 nm to 1000 nm and a power in the range of 1 mW to 500 mW; a beam homogenizing module that homogenizes the output beam of the treatment light source; a beam shaping module that modifies the output beam profile to produce a treatment light beam with an annular light beam profile; and a beam delivery and viewing module that allows an Operator to observe and operate to deliver the treatment light beam to the treatment location on the retina with an intensity in the range of 1 mW/cm2 to 500 mW/cm2.
    Type: Grant
    Filed: December 4, 2018
    Date of Patent: January 20, 2026
    Assignee: ELLEX MEDICAL PTY LTD.
    Inventors: Wei Xia, Victor Previn, Robert Casson
  • PHOTOBIOMODULATION DEVICE FOR TREATING RETINAL DISEASE
    Publication number: 20200360722
    Abstract: An ophthalmic treatment device for photobiomodulation of a retina comprising: a treatment light source producing a continuous wave or quasi-continuous wave output beam having a wavelength in the range of 600 nm to 1000 nm and a power in the range of 1 mW to 500 mW; a beam homogenizing module that homogenizes the output beam of the treatment light source; a beam shaping module that modifies the output beam profile to produce a treatment light beam with an annular light beam profile; and a beam delivery and viewing module that allows an Operator to observe and operate to deliver the treatment light beam to the treatment location on the retina with an intensity in the range of 1 mW/cm2 to 500 mW/cm2.
    Type: Application
    Filed: December 4, 2018
    Publication date: November 19, 2020
    Inventors: Wei Xia, Victor Previn, Robert Casson
  • Antagonistic anti-human CD40 monoclonal antibody
    Publication number: 20080085531
    Abstract: The present invention provides novel antagonistic anti-human CD40 monoclonal antibodies, methods for generating them and uses thereof.
    Type: Application
    Filed: May 9, 2007
    Publication date: April 10, 2008
    Inventors: Marcel Den Hartog, Ruprecht Van Neerven, Kevin Johnson, Robert Casson